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Knowledge of the pathophysiology of articular carti  lage is 
crucial in understanding the mechanisms under  lying 
joint diseases such as osteoarthritis (OA) and rheumatoid 
arthritis (RA). In a previous issue of Arthritis Research 
and Th  erapy, Berg and colleagues [1] have provided new 
insights in this ﬁ  eld by showing for the ﬁ  rst time that 
chondrocytes express chemerin and its cognate receptor, 
ChemR23, and that this system may be involved in 
cartilage degradation.
Chemerin is a secreted protein that exerts its functions 
by binding the G protein-coupled receptor ChemR23. It 
was ﬁ  rst discovered as a chemotactic peptide directing 
macrophages and dendritic cells expressing ChemR23 
toward sites of inﬂ   ammation, being involved in both 
adaptive and innate immunity [2]. As often happens, 
regulatory proteins have pleiotropic functions. ChemR23 
is also expressed by endothelial cells, where it is 
up-regulated by pro-inﬂ  ammatory cytokines, and chemerin 
strongly induces angiogenesis in vitro by promoting 
endothelial cell proliferation and remodeling through 
stimulation of matrix metalloproteinase (MMP) activity 
[3]. Interest in chemerin has grown since it was 
discovered in fat tissue as a novel adipokine secreted by 
adipocytes, which also express ChemR23. Chemerin is 
up-regulated in white fat cells upon IL-1β stimulation in 
vitro and chemerin serum levels are increased in obese 
patients; thus, chemerin may be the functional link 
between chronic inﬂ  ammation and obesity, and obesity-
related disorders such as type 2 diabetes and cardio-
vascular diseases [4].
Th  ere is evidence that chemokines may play an 
important role in recruiting inﬂ  ammatory cells into the 
joints and contribute to chronic synovitis in OA and RA 
[5]. Additionally, chemokines exert catabolic eﬀ  ects on 
cartilage. Functional chemokine receptors (CCR-1, CCR-2, 
CCR-3, CCR-5, CXCR-1, and CXCR-2) are detectable on 
human articular chondrocytes and up-regulated in OA 
cartilage. Th  e interactions of these receptors with their 
ligands activate matrix degradation by inducing MMP-3 
synthesis [6]. In their study, Berg and colleagues [1] 
explored whether chondrocytes also express ChemR23 
and investigated the metabolic eﬀ   ects of chemerin 
stimulation on chondrocytes. A series of experiments 
was performed on human native cartilage or cultured 
chondrocytes isolated from joints of patients undergoing 
knee arthroplasty for severe OA, and patients subjected 
to autologous chondrocyte transplantation. Cartilage 
from young subjects undergoing reconstruction of 
anterior cruciate ligament was taken as normal control. 
ChemR23 and prochemerin transcripts were detected in 
chondrocyte cultures by reverse transcriptase PCR. 
Furthermore, ChemR23 and chemerin proteins were 
detected in chondrocytes in vitro by immunocyto  chemis  try. 
Th  ese  ﬁ  ndings were conﬁ  rmed by immunohistochemistry 
in cartilage biopsies, in which resident chondrocytes 
showed positive staining for both ChemR23 and 
chemerin. Th  e eﬀ  ects of challenging isolated chondro-
cytes with recombinant chemerin in vitro were also 
investigated. Chemerin binding to ChemR23 led to 
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protein kinases (MAPKs) and Akt and blocking of 
MEK-1/2 signaling prevented phosphorylation of p44/42 
MAPKs but not of Akt. Th  is suggests that intracellular 
downstream events upon chemerin stimulation occur 
through the Akt/MEK/MAPK pathway. Th  e most out-
standing ﬁ  nding of this study was the demonstration that 
chemerin regulates the production of pro-inﬂ  ammatory 
cytokines and MMPs by human chondrocytes in vitro. 
IL-1β, TNF-α, IL-6, and IL-8 as well as MMP-13 and 
others MMPs were signiﬁ  cantly increased in the super-
natants of chondrocyte cultures stimulated with recom-
bi  nant chemerin. It is noteworthy that OA chondrocytes 
secreted larger amounts of cytokines than chondrocytes 
from healthy subjects. MMPs play a key role in the 
remodeling of cartilage matrix and their increase is 
crucial in the induction of cartilage damage in OA and 
RA. In OA, MMP-13 has been shown to be the most 
important collagenase and, together with ADAMTS-5 (a 
disintegrin and metalloproteinase with thrombospondin 
motifs-5), causes the breakdown of the collagen and 
aggre  can framework of the extracellular matrix and 
initiates the destruction of cartilage [7]. Consistent with 
this study, chemerin production by chondrocytes has also 
been reported by Conde and colleagues [8]. Th  ey have 
shown that chondrocytes synthesize chemerin and its 
expression is increased by IL-1β stimulation. Further-
more, dexametasone increased the eﬀ   ect of IL-1β on 
mRNA expression of chemerin by chondrocytes suggest-
ing that intra-articular injections of steroids as treatment 
of OA may damage the articular cartilage.
All together, these data strongly suggest that the 
chemerin/ChemR23 system is involved in cartilage 
damage in OA, and further studies will unravel its 
speciﬁ  c role. However, chemerin might not be one of the 
many redundant mediators that activate chondrocyte 
catabolic pathways, but may be a crucial link between 
obesity and OA. For years obesity has been regarded as a 
risk factor for developing OA in weight-bearing joints, 
but a growing body of evidence is showing that obesity is 
a mild inﬂ  ammatory disease and that a pro-inﬂ  ammatory 
network links fat tissue to obesity-related disease, 
including OA [9]. Chemerin is produced by adipocytes as 
well as chondrocytes and is up-regulated in both obesity 
and OA, and might be a promising ﬁ  eld of research to 
better understand and treat these two functionally 
associated diseases.
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